Since its founding in 2020, Tevogen Bio has developed a significant asset portfolio, and kept expenditures under $40 million, a ...

Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares are trading higher Monday, potentially driven by momentum from a late-Friday ...

Tevogen Bio Holdings Inc. (NASDAQ:TVGN) stock is moving higher on Wednesday after the company announced its artificial ...

By leveraging Microsoft's advanced tool collection, Tevogen Bio aims to establish an oncology product portfolio.

WARREN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty ...

We recently compiled a list of the 10 AI News and Ratings Investors Should Not Miss. In this article, we are going to take a ...

Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2. Forecast adds to Tevogen Bio's Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 ...

WARREN, N.J., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty ...

CD8 Technology Services, LLC (“CD8 Technology”) to provide turn-key facility for Tevogen Bio Reinforces Tevogen Bio’s commitment to preserving shareholder value Expected to further enhance ...

Microsoft Corporation (NASDAQ:MSFT) is a Washington-based technology company. On November 5, Tevogen Bio, a New Jersey-based biotech firm, announced that Tevogen AI, the AI department of the ...